Evidence map›Paper›PMID 38917323›Full record

ArticleNucleic acids research2024

Zika virus non-coding RNAs antagonize antiviral responses by PKR-mediated translational arrest.

Horacio M Pallarés, María Mora González López Ledesma, Santiago Oviedo-Rouco, Luciana A Castellano, Guadalupe S Costa Navarro, Ana J Fernández-Alvarez, María Josefina D'Andreiz, Victor Daniel Aldas-Bulos, Diego E Alvarez, Ariel A Bazzini and 1 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Cellular Biology: Virus-Host Interactions and RNA Structure and Function.Current topics in microbiology and immunology · 2026
    Review
  8. Animal virus-host interactions mediated by non-coding RNAs.Frontiers in cellular and infection microbiology · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Update on antimicrobial peptides: key elements inThe Journal of general virology · 2025
    Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Horacio M PallarésFundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires IIBBA-CONICET, Ciudad Autónoma de Buenos Aires, Argentina.
María Mora González López LedesmaFundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires IIBBA-CONICET, Ciudad Autónoma de Buenos Aires, Argentina.
Santiago Oviedo-RoucoFundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires IIBBA-CONICET, Ciudad Autónoma de Buenos Aires, Argentina.
Luciana A CastellanoStowers Institute for Medical Research, Kansas City, MO, USA.
Guadalupe S Costa NavarroFundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires IIBBA-CONICET, Ciudad Autónoma de Buenos Aires, Argentina.
Ana J Fernández-AlvarezFundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires IIBBA-CONICET, Ciudad Autónoma de Buenos Aires, Argentina.
María Josefina D'AndreizFundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires IIBBA-CONICET, Ciudad Autónoma de Buenos Aires, Argentina.
Victor Daniel Aldas-BulosStowers Institute for Medical Research, Kansas City, MO, USA.
Diego E AlvarezInstituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín-CONICET, Buenos Aires, Argentina.
Ariel A BazziniStowers Institute for Medical Research, Kansas City, MO, USA.
Andrea V GamarnikFundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires IIBBA-CONICET, Ciudad Autónoma de Buenos Aires, Argentina.ORCID 0000-0002-9789-4105

Funding

Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)U19AI168631 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ana Fernandez-Sesma · 2022 to 2026
$14.4M
Small translated ORFs in the 3'UTR enhance translation in vertebratesR01GM136849 · NIGMS · STOWERS INSTITUTE FOR MEDICAL RESEARCH · PI BAZZINI, ARIEL · 2021 to 2025
$2.0M
CRISPR-Cas13d: Transgenic zebrafish lines toknockdown mRNAR21OD034161 · OD · STOWERS INSTITUTE FOR MEDICAL RESEARCH · PI BAZZINI, ARIEL · 2023 to 2024
$454k
Argentinean Council of InvestigationCIHR-IRSC-ISF 495147Fondo Nacional para la Investigación Científica y Tecnológica PICT 2019-02869NIAID NIH HHS U19 AI168631NIGMS NIH HHS R01 GM136849NIH HHS R21 OD034161NIH HHS U19AI168631-01
6 · The paper itself

Abstract

Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that causes severe outbreaks in human populations. ZIKV infection leads to the accumulation of small non-coding viral RNAs (known as sfRNAs) that are crucial for evasion of antiviral responses and for viral pathogenesis. However, the mechanistic understanding of how sfRNAs function remains incomplete. Here, we use recombinant ZIKVs and ribosome profiling of infected human cells to show that sfRNAs block translation of antiviral genes. Mechanistically, we demonstrate that specific RNA structures present in sfRNAs trigger PKR activation, which instead of limiting viral replication, enhances viral particle production. Although ZIKV infection induces mRNA expression of antiviral genes, translation efficiency of type I interferon and interferon stimulated genes were significantly downregulated by PKR activation. Our results reveal a novel viral adaptation mechanism mediated by sfRNAs, where ZIKV increases its fitness by repurposing the antiviral role of PKR into a proviral factor.

Indexed as

eIF-2 KinaseProtein BiosynthesisRNA, ViralVirus ReplicationZika VirusZika Virus InfectionAnimalsCell LineChlorocebus aethiopsHEK293 CellsHumansRNA, UntranslatedEIF2AK2 protein, humaneIF-2 KinaseRNA, UntranslatedRNA, Viral

Identifiers

PMID38917323
PMCPMC11472168

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.